Skip to main content

Table 3 Immunohistochemical staining to each antigen of ESCC tissues

From: Phase I clinical study of multiple epitope peptide vaccine combined with chemoradiation therapy in esophageal cancer patients

Patients no. Immunohistochemistry*
HLA class I URLC10 TTK KOC1 VEGFR1 VEGFR2
1 + + + + + + + + + + + + + + +
2 + + + + + + + + + + + + + + + +
3 + + + + + + + + + + + + +
4 + + + + + + + + + + + + + + +
5 + + + + + + + + + + + + + + +
6 + + + + + + + + + + + + + + +
7 + + + + + + + + + + + + + + + +
8 + + + + + + + + + + + + +
9 + + + + + + + + + + + + + + + +
10 + + + + + + + + + + + + + +
11 + + + + + + + + + + + + + + + +
  1. *(+++): strong positive staining of more than 80%.
  2. (++): positive staining of 50-80%, (+): positive less than 50%.
  3. (-): no appreciable staining.
Back to article page